|
|
 |
|
Viewing report
|
|
|
|
Crohn’s Disease: Future Treatment Scenarios and Opportunities
Sociable Pharma, April 2011, Pages: 130
Changes in therapeutic strategies for Crohn's disease are set to have a profound impact on its treatment landscape, exacerbating current and generating new treatment challenges for doctors, while presenting new and potentially lucrative opportunities for current and future market players. Sociable Pharma conducted in-depth primary research in the US and across Europe with six key opinion leaders to understand how these changes will impact therapy use in the future and also gauged opinion during the European Crohn's & Colitis Organisation’s (ECCO) Annual Congress on the impact that new clinical data for existing and pipeline products will have on treatment strategies employed by inflammatory bowel disease specialists.
Report highlights:
- Identifies the latest treatment trends in Crohn's disease, including the growing importance of “top-down” treatment strategies for moderate-to-severe Crohn’s disease
- Based on key opinion leader interviews in the US and Europe, as well as the ECCO 2011 conference, supplemented with extensive secondary research on medical evidence and guidelines
Identifies commercial opportunities in Crohn's disease treatment including:
1. Targeting patients naïve to anti-TNF therapies with novel oral inhibitors
2. Combination therapies with helminth in mild-to-moderate disease
3. Improved localized release of corticosteroids to reduce systemic side effects
Assesses future scenarios for Crohn's disease therapies, including:
1. Migration of anti-TNF therapies to new treatment settings
2. Impact of tailored induction and maintenance regimens
3. Future use of antibiotics, probiotics and helminth in mild-to-moderate disease
Research highlights:
Identify commercial opportunities
- Targeting patients naïve to anti-TNF therapies with novel oral inhibitors
- Combination therapies with helminth in mild-to-moderate disease
- Improved localized release of corticosteroids to reduce systemic side effects
Assess future scenarios
- Migration of anti-TNF therapies to new treatment settings
- Impact of tailored induction and maintenance regimens
- Future use of antibiotics, probiotics and helminth in mild-to-moderate disease
Key features:
4 treatment maps & 53 treatment settings
- A visual guide to the treatment of Crohn’s disease, based on extensive primary and secondary research
32 commercial opportunities
- Opportunities for all major drug classes and treatment settings
Top 10 future scenarios
- Charts the potential winners and losers caused by drugs moving to earlier or new treatment settings as well as by the introduction of new therapies.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
